Dentsply Sirona Inc, a global leader in dental products and technologies with $3.67 billion in annual revenue, has seen its stock reach a 52-week low, closing at $12.14. According to InvestingPro ...
The integration enables automatic exchange of 2D X-ray data between DS Core and Second Opinion® chairside dental AI software. This seamless integration of DS Core, Dentsply Sirona’s cloud-based ...
Dentsply Sirona shares gained after the Securities and Exchange Commission concluded its investigation of the company. The stock rose 7% to $13.30 in after-hours trading Tuesday. Through the close, ...
The Division of Enforcement of the Securities and Exchange Commission has concluded its investigation into Dentsply Sirona Inc. (NASDAQ:XRAY) and does not intend to recommend any enforcement action ...
CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and ...
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential ...
The special video shows that the love of the "Peanuts" gang has made it through generations of the Schulz family Charles M. Schulz Museum/Instagram; Alamy It has been 75 years since the "Peanuts" ...
An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers and supported by the ...
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback